Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (201-210 of 260) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cellsS Aebi, D Fink, R Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
In vitro antineoplastic activity of a novel lanthionine-containing peptideH Zheng, D Fink, H Li, et al.
British Journal of Cancer|March 31, 1999
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cellsA Nehmé, R Baskaran, S Nebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamoleR Goel, S M Cleary, C Horton, et al.
British Journal of Cancer|March 26, 1998
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cellsD Fink, S Nebel, P S Norris, et al.
British Journal of Cancer|January 1, 1997
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissuesD Fink, S Nebel, S Aebi, et al.
Oncogene|July 1, 1994
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cellsR J Pietras, B M Fendly, V R Chazin, et al.
Genomics|September 15, 1996
Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporterB Kurdi-Haidar, S Aebi, D Heath, et al.
Cancer Research|September 1, 1996
Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatinE F McClay, J A Jones, P J Winski, et al.
Molecular and Cellular Biology|September 11, 1992
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell linesW Zhen, C J Link, P M O'Connor, et al.
Pageof 26

Showing results (201-210 of 260) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cellsS Aebi, D Fink, R Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
In vitro antineoplastic activity of a novel lanthionine-containing peptideH Zheng, D Fink, H Li, et al.
British Journal of Cancer|March 31, 1999
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cellsA Nehmé, R Baskaran, S Nebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamoleR Goel, S M Cleary, C Horton, et al.
British Journal of Cancer|March 26, 1998
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cellsD Fink, S Nebel, P S Norris, et al.
British Journal of Cancer|January 1, 1997
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissuesD Fink, S Nebel, S Aebi, et al.
Oncogene|July 1, 1994
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cellsR J Pietras, B M Fendly, V R Chazin, et al.
Genomics|September 15, 1996
Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporterB Kurdi-Haidar, S Aebi, D Heath, et al.
Cancer Research|September 1, 1996
Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatinE F McClay, J A Jones, P J Winski, et al.
Molecular and Cellular Biology|September 11, 1992
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell linesW Zhen, C J Link, P M O'Connor, et al.
Pageof 26